UBS has revised its price target for Keurig Dr Pepper (KDP, Financial), reducing it from $42 to $40. Despite this change, the financial institution continues to uphold a Buy rating for the beverage company's shares. This adjustment reflects UBS's updated evaluation while maintaining confidence in the company's potential for growth.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 19 analysts, the average target price for Keurig Dr Pepper Inc (KDP, Financial) is $38.91 with a high estimate of $44.00 and a low estimate of $34.00. The average target implies an upside of 17.17% from the current price of $33.21. More detailed estimate data can be found on the Keurig Dr Pepper Inc (KDP) Forecast page.
Based on the consensus recommendation from 22 brokerage firms, Keurig Dr Pepper Inc's (KDP, Financial) average brokerage recommendation is currently 2.1, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Keurig Dr Pepper Inc (KDP, Financial) in one year is $39.07, suggesting a upside of 17.65% from the current price of $33.21. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Keurig Dr Pepper Inc (KDP) Summary page.
